Clinton Musil compensation by year
GYRE THERAPEUTICS Summary Compensation Table · all 2 fiscal years held| Component | FY2020 | FY2021 |
|---|---|---|
| Salary | $197,691 | $389,734 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $696,142 | $239,890 |
| Non-equity incentive | $66,490 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $6,589 | $20,000 |
| Total | $966,912 | $649,624 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GYRE THERAPEUTICS, INC. DEF 14A filed July 19, 2022, accession 0001140361-22-026309, and prior-year filings.
How this page was built: the GYRE THERAPEUTICS, INC. filed document, accession 0001140361-22-026309. Every figure is read from that document and cited to the page and table it appears in. Filed July 19, 2022.
GYRE THERAPEUTICS’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Nassim Usman | President and Chief Executive Officer | $1,235,751 |
| Grant Blouse | Chief Scientific Officer | $736,694 |
| Clinton Musil · this page | Former Chief Financial Officer | $649,624 |
| M.B.B.Ch. Howard Levy | Former Chief Medical Officer | $618,254 |
| Seline Miller | Interim Chief Financial Officer | $313,339 |
The full GYRE THERAPEUTICS compensation record
free company briefThis page is one person within GYRE THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GYRE THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.